July 1, 2009 - Elekta has formed an investment company, Global Medical Investments "GMI", with Swedfund International AB for financing and establishment of cancer care projects in developing countries.

Global Medical Investments, GMI, will invest, develop and support the establishment of cancer management programs in developing countries across the world in cooperation with local healthcare providers and partners.

Through GMI, Swedfund and Elekta will be able to provide technology and competence for advanced cancer management. Elekta and Swedfund will each invest up to USD 10 M in GMI. Through this initiative Elekta will also strengthen its presence in countries where the company has limited business activities.

GMI is currently in the final stage of development of the first sophisticated radiotherapy center in Accra, Ghana. This is developed in close collaboration with Scandinavian Care Projects AB, which is leading this project, and with local partners. The cancer center is expected to initiate treatment in the first half of 2010, and will give the people in Ghana access to effective and cost efficient cancer treatment with Elekta’s latest technology.

“We believe that this investment, with Swedish expertise in healthcare and medical technology, will contribute to increased availability of advanced medical care. Swedfund participated in the financing of the first GammaKnife in Africa, which is located in Egypt, and we are very pleased by this extended cooperation which we believe will lead to many new cancer centers in developing countries," saids Björn Blomberg, managing director of Swedfund.

For more information: www.swedfund.se and www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now